Similar Search Results

The impact of the entry of biosimilars : evidence from Europe

Scott Morton, Fiona; Stern, Ariel D.; Stern, Scott - In: Review of industrial organization : RIO 53 (2018) 1, pp. 173-210

Persistent link: https://www.econbiz.de/10012009103

Special FDA designations for drug development : orphan, fast track, accelerated approval, priority review, and breakthrough therapy

Michaeli, Daniel; Michaeli, Christoph T.; Albers, Sebastian - In: The European journal of health economics 25 (2024) 6, pp. 979-997

Persistent link: https://www.econbiz.de/10014633366

The impact of R&D cooperations on drug variety offered on the market : evidence from the pharmaceutical industry

Banerjee, Tannista; Siebert, Ralph - 2014

Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...

Persistent link: https://www.econbiz.de/10010229875

The EU's open strategic autonomy in the field of pharmaceuticals : overcoming import dependencies for antibiotics through the EU authority HERA

Bayerlein, Michael - Stiftung Wissenschaft und Politik - 2023

identifying and eliminating import dependencies in the field of pharmaceuticals. HERA’s work thus aligns with current EU efforts …

Persistent link: https://www.econbiz.de/10013540432

From scientific research to healthcare markets : empirical essays on the economics of pharmaceutical innovation

Byrski, Dennis - 2021

Persistent link: https://www.econbiz.de/10012816525

Evaluating the US pharmaceutical patent policy

Izhak, Olena; Saxell, Tanja; Takalo, Tuomas - 2021

The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...

Persistent link: https://www.econbiz.de/10012802183

Advances in pharma business management and research : volume 1

Schweizer, Lars (ed.); Dingermann, Theodor (ed.); … - 2020

This open access book presents a unique collection of practical examples from the field of pharma business management and research. It covers a wide range of topics such as: 'Brexit and its Impact on pharmaceutical Law - Implications for Global Pharma Companies', 'Implementation of Measures and...

Persistent link: https://www.econbiz.de/10013473290

Public debate : the US food and drug administration and new drug approvals ; a safety vs. innovation paradox?

Hemphill, Thomas A. - In: Innovation: organization & management : IOM 15 (2013) 3, pp. 364-367

Persistent link: https://www.econbiz.de/10010226637

Competition between originators and generics : public regulation and incentives to innovate

Campion, Marie-Geneviève - 2015

The aim of this thesis is to examine the competition patterns that exist between originators and generics by focusing …-containment measures and innovation issues is performed, then in the second chapter, an empirical study is performed to investigate … price for off-patent markets can contribute in promoting innovation. Finally, in the fourth chapter, the modeling of risk …

Persistent link: https://www.econbiz.de/10011432290

Has pharmaceutical innovation reduced the average cost of U.S. health care episodes?

Lichtenberg, Frank R. - In: International journal of health economics and management 24 (2024) 1, pp. 1-31

Persistent link: https://www.econbiz.de/10014547929

1
2
3
4
5
6
7
8
9
10
Next
Last